| Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support J Grebely, E Knight, KA Genoway, M Viljoen, M Khara, D Elliott, ... European journal of gastroenterology & hepatology 22 (3), 270-277, 2010 | 153 | 2010 |
| Reinfection with hepatitis C virus following sustained virological response in injection drug users J Grebely, E Knight, T Ngai, KA Genoway, JD Raffa, M Storms, ... Journal of gastroenterology and hepatology 25 (7), 1281-1284, 2010 | 120 | 2010 |
| Evaluation of a tool to score donor vein suitability for blood donation MP Hirani R, O'Donovan J, Knight E, Bell B Vox Sanguinis, 2019 | 8 | 2019 |
| Evaluation of a sterile surgical skin marker to indicate the optimal vein for venepuncture in the blood donation setting B Bell, J O’Donovan, ST Wright, CN Gemelli, E Knight, R Hirani Vox Sanguinis 115 (5), 377-387, 2020 | 3 | 2020 |
| Hepatitis C virus (HCV) infection and re-infection among HCV-and HIV/HCV-infected injection drug users B Conway, A Barrieshee, HK Tossonian, K Wight, S Jassemi, M Tong, ... Journal of the International AIDS Society 13, 1-1, 2010 | 1 | 2010 |
| P‐BT‐11| Evaluation of Serum Eyedrop MEISE Vial Packaging for Australian Patients R Hirani, P Mondy, C Gemelli, A Kakkos, J O'Donovan, C Willis, P Diaz, ... Transfusion 63, 77A-77A, 2023 | | 2023 |
| Patient-reported outcomes of serum eye drops manufactured from Australian blood donations and packaged using Meise vials CN Gemelli, P Mondy, A Kakkos, J O’Donovan, P Diaz, E Knight, R Hirani Frontiers in Medicine 10, 1252688, 2023 | | 2023 |
| Evaluation of a sterile surgical skin marker to indicate the optimal vein for venepuncture in the blood donation setting (vol 115, pg 377, 2020) B Bell, J O'Donovan, ST Wright, CN Gemelli, E Knight, R Hirani VOX SANGUINIS 117 (2), 293-293, 2022 | | 2022 |
| Limited uptake of ulcerative colitis RV Bryant, SP Costello, S Schoeman, D Sathananthan, E Knight, SY Lau, ... Journal of Gastroenterology and Hepatology 33 (3), 2018 | | 2018 |
| DETERMINANTS OF ENGAGEMENT IN CARE OF INNER CITY HCV-INFECTED INJECTION DRUG USERS (IDUS): 887 B Conway, H Tossonian, J Grebely, JD Raffa, M Krahn, MM Storms, ... Hepatology 50, 722A, 2009 | | 2009 |
| Substitution of tenofovir for nucleoside analogues in virologically controlled HIV-infected patients co-infected with hepatitis C virus: TEN-SWITCH J Grebely, L Gallagher, E Knight, K Genoway, M Storms, HK Tossonian, ... Journal of the International AIDS Society 11, 1-2, 2008 | | 2008 |
| Low rate of hepatitis C virus re-infection following sustained virological response among injection drug users having received treatment for HCV infection J Grebely, T Ngai, E Knight, JD Raffa, KA Genoway, G Showler, F Duncan, ... JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 23, A338-A338, 2008 | | 2008 |
| Safety and efficacy of substituting tenofovir for other nucleoside analogues in virologically controlled HIV-infected patients co-infected with hepatitis C virus: the ten … J Grebely, L Gallagher, E Knight, KA Genoway, M Storms, HK Tossonian, ... JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 23, A369-A369, 2008 | | 2008 |
| THREE YEAR FOLLOW-UP OF A MULTIDISCIPLINARY CARE AND PEER SUPPORT MODEL FOR THE ENGAGEMENT OF IDUS IN CARE AND TREATMENT FOR HCV INFECTION J Grebely, E Knight, T Ngai, K Genoway, F Duncan, MI Viljoen, M Storms, ... HEPATOLOGY 48 (4), 891A-891A, 2008 | | 2008 |
| Optimizing assessment and treatment for hepatitis C virus (HCV) infection in illicit drug users: a model incorporating multidisciplinary care and peer-support F Duncan, J Grebely, E Knight, T Ngai, K Genoway, M Viljoen, M Storms, ... JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 23, A352-A353, 2008 | | 2008 |
Jason GrebelyProfessor, The Kirby Institute, UNSW Sydney在 kirby.unsw.edu.au 的电子邮件经过验证
